{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T09:26:55Z","timestamp":1782552415706,"version":"3.54.5"},"reference-count":61,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI Grant-in-Aid for Scientific Research (C)","doi-asserted-by":"publisher","award":["21K02383"],"award-info":[{"award-number":["21K02383"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Background: The COVID-19 pandemic had profound impacts worldwide on individuals with mental and behavioral disorders, including disorders due to psychoactive substance use. We investigated how the COVID-19 pandemic affected the trends in these disorders in the Republic of Kazakhstan. Methods: We researched and compared ICD-10 data on mental and behavioral disorders due to substance use in Kazakhstan that were diagnosed in 2018\u20132019 (pre-pandemic) versus 2020\u20132021 (the pandemic period). Results: The data for the pandemic period were significantly different from those of the pre-pandemic in that (i) \u2018other stimulant-related disorders (F15)\u2019 and \u2018other psychoactive substance-related disorders (F19)\u2019 were increased in the younger age groups, (ii) the risk of \u2018opioid-related disorders (F11)\u2019 was decreased in the 30-year-old group in both males and females, and (iii) the risk of \u2018alcohol-related disorders (F10)\u2019 was increased in the 30-year-old group and decreased in the 20- and 50-year-old groups. In only the males, (iv) the risk of \u2018other psychoactive substance-related disorders (F19)\u2019 was increased in almost all of the age groups, and (v) the risk of \u2018cannabis-related disorders (F12)\u2019 was increased in the \u226550-year-olds. The pre-pandemic and pandemic periods thus involved changes due to COVID-19 in both males and females that were especially notable in males. Conclusions: These results indicate that further measures designed to prevent mental and behavioral disorders due to psychoactive substances are necessary at the primary, secondary, and tertiary levels, and personnel in medicine\/nursing, the government, private organizations, and the public need to collaborate to devise such measures.<\/jats:p>","DOI":"10.3390\/healthcare12202012","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T07:54:09Z","timestamp":1728546849000},"page":"2012","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Differences in the Rates of Diagnoses of Mental and Behavioral Disorders Due to Psychoactive Substance Use by Sex and Age during Pre-Pandemic and COVID-19 Pandemic Periods in Kazakhstan"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6294-4168","authenticated-orcid":false,"given":"Kamila","family":"Akkuzinova","sequence":"first","affiliation":[{"name":"Board, Semey Medical University, Semey 071400, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0710-481X","authenticated-orcid":false,"given":"Ken","family":"Inoue","sequence":"additional","affiliation":[{"name":"Research and Education Faculty, Medical Sciences Cluster, Health Service Center, Kochi University, Kochi 780-8520, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0112-3744","authenticated-orcid":false,"given":"Elaman","family":"Toleuov","sequence":"additional","affiliation":[{"name":"Board, Semey Medical University, Semey 071400, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4385-8459","authenticated-orcid":false,"given":"Timur","family":"Moldagaliyev","sequence":"additional","affiliation":[{"name":"Board, Semey Medical University, Semey 071400, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6276-3546","authenticated-orcid":false,"given":"Nursultan","family":"Seksenbayev","sequence":"additional","affiliation":[{"name":"Board, Semey Medical University, Semey 071400, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1671-289X","authenticated-orcid":false,"given":"Ulzhan","family":"Jamedinova","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, Semey Medical University, Semey 071400, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9316-6389","authenticated-orcid":false,"given":"Nargul","family":"Ospanova","sequence":"additional","affiliation":[{"name":"Board, Semey Medical University, Semey 071400, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0875-1020","authenticated-orcid":false,"given":"Altay","family":"Dyussupov","sequence":"additional","affiliation":[{"name":"Board, Semey Medical University, Semey 071400, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (WHO) (2024, June 10). International Statistical Classification of Diseases and Related Health Problems 10th Revision. Available online: https:\/\/icd.who.int\/browse10\/2019\/en#\/F10-F19."},{"key":"ref_2","unstructured":"World Health Organization (WHO) (2024, June 10). International Classification of Diseases Eleventh Revision (ICD-11). Available online: https:\/\/icd.who.int\/browse\/2024-01\/mms\/en#1602669465."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (APA) (2022). Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR, American Psychiatric Association Publishing. [5th ed.]. Text Revision.","DOI":"10.1176\/appi.books.9780890425787"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/09540261.2022.2040450","article-title":"Analysis of Global Prevalence of Mental and Substance Use Disorders within Countries: Focus on Sociodemographic Characteristics and Income Levels","volume":"34","author":"Bhugra","year":"2022","journal-title":"Int. Rev. Psychiatry"},{"key":"ref_5","unstructured":"World Health Organization (WHO) (2018). Global Status Report on Alcohol and Health 2018, World Health Organization. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/274603\/9789241565639-eng.pdf."},{"key":"ref_6","unstructured":"United Nations Office on Drugs and Crime (2020). Executive Summary\/Impact of COVID-19\/Policy implications. World Drug Report 2020, United Nations Publication. Available online: https:\/\/wdr.unodc.org\/wdr2020\/field\/WDR20_BOOKLET_1.pdf."},{"key":"ref_7","unstructured":"United Nations Office on Drugs and Crime (2020). Executive summary\/Policy implications. World Drug Report 2021, United Nations Publication. Available online: https:\/\/www.unodc.org\/res\/wdr2021\/field\/WDR21_Booklet_1.pdf."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/add.14234","article-title":"Global statistics on alcohol, tobacco and illicit drug use: 2017 status report","volume":"113","author":"Peacock","year":"2018","journal-title":"Addiction"},{"key":"ref_9","unstructured":"GBD 2019 Tobacco Collaborators (2021). Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990\u20132019: A systematic analysis from the Global Burden of Disease Study 2019. Lancet, 397, 2337\u20132360."},{"key":"ref_10","unstructured":"WHO Regional Office for Europe (2022). A Timeline of WHO\u2019s COVID-19 Response in the WHO European Region: A Living Document (Version 3.0, from 31 December 2019 to 31 December 2021), WHO Regional Office for Europe. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/351782\/WHO-EURO-2022-1772-41523-63024-eng.pdf."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Wei, Y., and Shah, R. (2020). Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications. Pharmaceuticals, 13.","DOI":"10.20944\/preprints202007.0061.v1"},{"key":"ref_12","first-page":"85","article-title":"COVID-19 pandemic and social distancing: Economic, psychological, family, and technological effects","volume":"43","author":"Both","year":"2021","journal-title":"Trends Psychiatry Psychother."},{"key":"ref_13","unstructured":"COVID-19 Excess Mortality Collaborators (2022). Estimating excess mortality due to the COVID-19 pandemic: A systematic analysis of COVID-19-related mortality, 2020\u20132021. Lancet, 399, 1513\u20131536."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.dsx.2020.05.035","article-title":"Psychosocial impact of COVID-19","volume":"14","author":"Dubey","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1017\/S0033291720000999","article-title":"Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China","volume":"51","author":"Bo","year":"2021","journal-title":"Psychol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2020.08.001","article-title":"Impact of COVID-19 pandemic on mental health in the general population: A systematic review","volume":"277","author":"Xiong","year":"2020","journal-title":"J. Affect. Disord."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Maye, C.E., Wojcik, K.D., Candelari, A.E., Goodman, W.K., and Storch, E.A. (2022). Obsessive compulsive disorder during the COVID-19 pandemic: A brief review of course, psychological assessment and treatment considerations. J. Obs. Compuls. Relat. Disord., 33.","DOI":"10.1016\/j.jocrd.2022.100722"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s40429-020-00321-z","article-title":"Directional Effects of Anxiety and Depressive Disorders with Substance Use: A Review of Recent Prospective Research","volume":"7","author":"Garey","year":"2020","journal-title":"Curr. Addict. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/15504263.2020.1825892","article-title":"Impact of Substance Use Disorder on Quality of Inpatient Mental Health Services for People with Anxiety and Depression","volume":"17","author":"Williams","year":"2021","journal-title":"J. Dual. Diagn."},{"key":"ref_20","first-page":"101","article-title":"Stress and Substance Misuse","volume":"Volume 6","author":"Moeller","year":"2020","journal-title":"Substance Use Disorders"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Clair, R., Gordon, M., Kroon, M., and Reilly, C. (2021). The effects of social isolation on well-being and life satisfaction during pandemic. Humanit. Soc. Sci. Commun., 8.","DOI":"10.1057\/s41599-021-00710-3"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1080\/10826084.2021.1901934","article-title":"The Early Impact of Social Distancing Measures on Drug Use","volume":"56","author":"Christie","year":"2021","journal-title":"Subst. Use Misuse"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11920-022-01338-z","article-title":"Substance Use Among Youth During the COVID-19 Pandemic: A Systematic Review","volume":"24","author":"Layman","year":"2022","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Deimel, D., Firk, C., St\u00f6ver, H., Hees, N., Scherbaum, N., and Flei\u00dfner, S. (2022). Substance Use and Mental Health during the First COVID-19 Lockdown in Germany: Results of a Cross-Sectional Survey. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph191912801"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Sugaya, N., Yamamoto, T., Suzuki, N., and Uchiumi, C. (2021). Alcohol Use and Its Related Psychosocial Effects during the Prolonged COVID-19 Pandemic in Japan: A Cross-Sectional Survey. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph182413318"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41380-020-00880-7","article-title":"COVID-19 risk and outcomes in patients with substance use disorders: Analyses from electronic health records in the United States","volume":"26","author":"Wang","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1176\/appi.ps.202000534","article-title":"The Impact of Substance Use Disorder on COVID-19 Outcomes","volume":"72","author":"Baillargeon","year":"2021","journal-title":"Psychiatr. Serv."},{"key":"ref_28","first-page":"133","article-title":"COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position Paper","volume":"11","author":"Farhoudian","year":"2020","journal-title":"Basic Clin. Neurosci."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Jemberie, W.B., Stewart Williams, J., Eriksson, M., Gr\u00f6nlund, A.S., Ng, N., Blom Nilsson, M., Padyab, M., Priest, K.C., Sandlund, M., and Snellman, F. (2020). Substance Use Disorders and COVID-19: Multi-Faceted Problems Which Require Multi-Pronged Solutions. Front. Psychiatry, 11.","DOI":"10.3389\/fpsyt.2020.00714"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ornell, F., Moura, H.F., Scherer, J.N., Pechansky, F., Kessler, F.H.P., and von Diemen, L. (2020). The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment. Psychiatry Res., 289.","DOI":"10.1016\/j.psychres.2020.113096"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lee, J., Park, S., Jang, S.N., Reyes, K.A., Garcia, F.J., Canila, C., Ora\u00f1o, J., Ballesteros, A.J., Muhartini, T., and Frans, S. (2024). Differential impacts of health systems and sociocultural environment on vulnerable populations during the COVID-19 pandemic: Lessons from four Asia-Pacific countries. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-18949-1"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S2215-0366(21)00025-0","article-title":"COVID-19 mental health impact and responses in low-income and middle-income countries: Reimagining global mental health","volume":"8","author":"Kola","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kumar, N., Janmohamed, K., Nyhan, K., Martins, S.S., Cerda, M., Hasin, D., Scott, J., Sarpong Frimpong, A., Pates, R., and Ghandour, L.A. (2022). Substance, use in relation to COVID-19: A scoping review. Addict. Behav., 127.","DOI":"10.1016\/j.addbeh.2021.107213"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Rezaeiahari, M., and Fairman, B.J. (2022). Impact of COVID-19 on the characteristics of opioid overdose deaths in Arkansas. Int. J. Drug Policy, 109.","DOI":"10.1016\/j.drugpo.2022.103836"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1001\/jama.2022.4308","article-title":"Alcohol-Related Deaths During the COVID-19 Pandemic","volume":"327","author":"White","year":"2022","journal-title":"JAMA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jad.2021.09.059","article-title":"Comparing mortality from COVID-19 to mortality due to overdose: A micromort analysis","volume":"296","author":"Lee","year":"2022","journal-title":"J. Affect. Disord."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Pelayo, H., Aubin, H.J., Drummond, C., Dom, G., Pascual, F., Rehm, J., Saitz, R., Scafato, E., and Gual, A. (2020). \u201cThe post-COVID era\u201d: Challenges in the treatment of substance use disorder (SUD) after the pandemic. BMC Med., 18.","DOI":"10.1186\/s12916-020-01693-9"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s10461-020-02976-1","article-title":"Potential Influences of the COVID-19 Pandemic on Drug Use and HIV Care Among People Living with HIV and Substance Use Disorders: Experience from a Pilot mHealth Intervention","volume":"25","author":"Hochstatter","year":"2021","journal-title":"AIDS Behav."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/YCO.0000000000000720","article-title":"Effects of the COVID-19 pandemic and lockdown on alcohol use disorders and complications","volume":"34","author":"Murthy","year":"2021","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Nitta, K., Naito, H., Tabuchi, T., and Kakiuchi, Y. (2024). Fear of COVID-19 and illicit drug use during COVID-19 pandemic in Japan: A case-control study. PeerJ, 12.","DOI":"10.7717\/peerj.18137"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Cisneros, I.E., and Cunningham, K.A. (2021). Covid-19 interface with drug misuse and substance use disorders. Neuropharmacology, 198.","DOI":"10.1016\/j.neuropharm.2021.108766"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Bergman, B.G., and Kelly, J.F. (2021). Online digital recovery support services: An overview of the science and their potential to help individuals with substance use disorder during COVID-19 and beyond. J. Subst. Abuse Treat., 120.","DOI":"10.1016\/j.jsat.2020.108152"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/ajae.12158","article-title":"COVID-19 and Supply Chain Disruption: Evidence from Food Markets in India","volume":"103","author":"Mahajan","year":"2021","journal-title":"Am. J. Agric. Econ."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Parvanta, C., Caban-Martinez, A.J., Cabral, N., Ball, C.K., Moore, K.G., Eastlake, A., Levin, J.L., Nessim, D.E., These, M.S., and Schulte, P.A. (2022). In Search of a Value Proposition for COVID-19 Testing in the Work Environment: A Social Marketing Analysis. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph191912496"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10654-023-01068-3","article-title":"The impact of the COVID-19 pandemic on mortality in Sweden\u2014Did it differ across socioeconomic groups?","volume":"39","author":"Ramstedt","year":"2024","journal-title":"Eur. J. Epidemiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00228-021-03238-2","article-title":"Hospitalizations and deaths related to adverse drug events worldwide: Systematic review of studies with national coverage","volume":"78","author":"Silva","year":"2022","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Bakaloudi, D.R., Evripidou, K., Jayawardena, R., Breda, J., Dardavessis, T., Poulia, K.A., and Chourdakis, M. (2022). The Impact of Lockdowns on Caffeine Consumption: A Systematic Review of the Evidence. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19095255"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Fernandes, S., Sosa-Napolskij, M., Lobo, G., and Silva, I. (2021). Impact of the COVID-19 pandemic in the Portuguese population: Consumption of alcohol, stimulant drinks, illegal substances, and pharmaceuticals. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0260322"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Tracy, K., Wachtel, L., and Friedman, T. (2021). The impact of COVID-19 on opioid treatment program (OTP) services: Where do we go from here?. J. Subst. Abuse Treat., 131.","DOI":"10.1016\/j.jsat.2021.108394"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/07853890.2022.2067350","article-title":"Opioid overdose decedent characteristics during COVID-19","volume":"54","author":"Garcia","year":"2022","journal-title":"Ann. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"535","DOI":"10.24869\/psyd.2022.535","article-title":"The Incidence of Alcohol Use Disorders during the COVID-19 Pandemic","volume":"34","author":"Sarfraz","year":"2022","journal-title":"Psychiatr. Danub."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/10547738221136678","article-title":"COVID-19 Concerns, Perceived Stress, and Increased Alcohol Use Among Adult Women in the United States","volume":"32","author":"Grigsby","year":"2023","journal-title":"Clin. Nurs. Res."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Carfora, A., Petrella, R., Ambrosio, G., Fracassi, I., Festinese, S., Feola, A., and Campobasso, C.P. (2022). Toxicological Analysis of Illicit Drugs Seized in Naples (Italy) and First Detection of Synthetic Cannabinoids during COVID-19 Pandemic. Healthcare, 10.","DOI":"10.3390\/healthcare10081488"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.biopsych.2015.08.001","article-title":"Association Between Cannabis and Psychosis: Epidemiologic Evidence","volume":"79","author":"Gage","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"309","DOI":"10.31887\/DCNS.2017.19.3\/glafaye","article-title":"Cannabis, cannabinoids, and health","volume":"19","author":"Lafaye","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Abate, B.B., Kassie, A.M., Kassaw, M.W., Aragie, T.G., and Masresha, S.A. (2020). Sex difference in coronavirus disease (COVID-19): A systematic review and meta-analysis. BMJ Open, 10.","DOI":"10.1136\/bmjopen-2020-040129"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Wang, X., Peng, P., Liu, Y., Yang, W.F., Chen, S., Wang, Y., Yang, Q., Li, M., Wang, Y., and Hao, Y. (2023). Gender differences in alcohol abuse\/dependence among medical undergraduates during the post-COVID 19 pandemic period (October 20, 2020\u2013April 5, 2021) in China. BMC Psychiatry, 23.","DOI":"10.1186\/s12888-023-05260-3"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Babicki, M. (2022). Use of Alcohol, Cannabinoids, Psychostimulants, and Sedatives before and during the COVID-19 Pandemic among Students in 40 European Countries. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph192214879"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Inoue, K., Hashioka, S., Takeshita, H., Fujita, Y., Moriwaki, S., Murayama, Y., Fujita, Y., Matsumoto, H., Takeichi, N., and Hoshi, M. (2020). Drug offenses in the Tokyo Metropolitan Area: Trends for 2016\u20132018. Leg. Med., 47.","DOI":"10.1016\/j.legalmed.2020.101739"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s00127-021-02091-z","article-title":"Emergency hospital admissions for psychiatric disorders in a German-wide hospital network during the COVID-19 outbreak","volume":"56","author":"Fasshauer","year":"2021","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jpsychires.2022.08.019","article-title":"Association between mental disorders and COVID-19 outcomes among inpatients in France: A retrospective nationwide population-based study","volume":"155","author":"Descamps","year":"2022","journal-title":"J. Psychiatr. Res."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/12\/20\/2012\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:10:16Z","timestamp":1760112616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/12\/20\/2012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":61,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["healthcare12202012"],"URL":"https:\/\/doi.org\/10.3390\/healthcare12202012","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,10]]}}}